Immix Biopharma (IMMX) Prepaid Assets (2020 - 2026)

Immix Biopharma has reported Prepaid Assets for 7 years, with the latest figure at $335739.0 in Q1 2026.

• Quarterly Prepaid Assets rose 98.56% year-over-year to $335739.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $335739.0 (up 98.56% YoY) and the FY2025 annual result came in at $179903.0, up 1827.39% from the prior year.
• Prepaid Assets improved to $335739.0 in Q1 2026 per IMMX's latest filing, from $179903.0 in the prior quarter.
• Over five years, Prepaid Assets peaked at $2.6 million in Q2 2023 and troughed at $9334.0 in Q4 2024.
• A 5-year average of $573217.2 and a median of $263927.0 in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2024 and 2025: Prepaid Assets tumbled 98.26% in 2024, then soared 1827.39% in 2025.
• Over 5 years, Prepaid Assets stood at $78067.0 in 2022, then soared by 238.08% to $263927.0 in 2023, then sank by 96.46% to $9334.0 in 2024, then jumped by 1827.39% to $179903.0 in 2025, then soared by 86.62% to $335739.0 in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $335739.0, $179903.0, and $49647.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.